Victory Capital Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.4K | Sell |
21,285
-329
| -2% | -$1.12K | ﹤0.01% | 2357 |
|
|
2025
Q1 | $86.7K | Sell |
21,614
-439
| -2% | -$1.76K | ﹤0.01% | 2323 |
|
|
2024
Q4 | $143K | Sell |
22,053
-692
| -3% | -$4.49K | ﹤0.01% | 2289 |
|
|
2024
Q3 | $126K | Sell |
22,745
-255
| -1% | -$1.41K | ﹤0.01% | 2293 |
|
|
2024
Q2 | $128K | Buy |
23,000
+835
| +4% | +$4.66K | ﹤0.01% | 2265 |
|
|
2024
Q1 | $149K | Buy |
22,165
+607
| +3% | +$4.07K | ﹤0.01% | 2257 |
|
|
2023
Q4 | $197K | Sell |
21,558
-7,820
| -27% | -$71.3K | ﹤0.01% | 2239 |
|
|
2023
Q3 | $162K | Sell |
29,378
-3,497
| -11% | -$19.3K | ﹤0.01% | 2234 |
|
|
2023
Q2 | $281K | Buy |
32,875
+4,161
| +14% | +$35.5K | ﹤0.01% | 2130 |
|
|
2023
Q1 | $264K | Buy |
+28,714
| New | +$264K | ﹤0.01% | 2180 |
|
|
2022
Q3 | – | Sell |
-10,379
| Closed | -$111K | – | 2713 |
|
|
2022
Q2 | $111K | Sell |
10,379
-26
| -0.2% | -$278 | ﹤0.01% | 2451 |
|
|
2022
Q1 | $98K | Sell |
10,405
-295
| -3% | -$2.78K | ﹤0.01% | 2515 |
|
|
2021
Q4 | $175K | Buy |
+10,700
| New | +$175K | ﹤0.01% | 2507 |
|